Ad copy

Taking Keytruda® or Opdivo®? Cancer Stable or Growing? Adults in Gold Coast whose cancer is stable or progressing despite immunotherapy (Keytruda® or Opdivo®) may qualify for a clinical study. Qualifying cancers: • Lung cancer (non-small cell) • Melanoma • Bladder or kidney cancer • Colorectal cancer (MSI-H) • Stomach, esophageal, head/neck, or cervical cancer • Mesothelioma Who qualifies: ✓ Currently taking or recently stopped Keytruda® or Opdivo® ✓ Cancer is stable or progressing ✓ Able to perform light daily activities What’s involved: • Weekly visits followed by ongoing monitoring over 12 months. • Study is investigating how filtering extracellular vesicles may help cancer patients. Reimbursement for travel, meals, and lodging available. Take the 2-minute eligibility questionnaire